HLB Pharmaceutical Co., Ltd. (KOSDAQ:047920)
South Korea flag South Korea · Delayed Price · Currency is KRW
6,830.00
+30.00 (0.44%)
Nov 17, 2026, 3:30 PM KST

HLB Pharmaceutical Cash Flow Statement

Millions KRW. Fiscal year is Jan - Dec.

Operating Activities

Fiscal Year
TTMFY 2025FY 2024FY 2019FY 2018FY 2017
Period Ending
Sep '26 Dec '25 Dec '24 Dec '19 Dec '18 Dec '17
Net Income
3,3754,5722,020472.65-7,060-5,447
Depreciation & Amortization
4,8124,1125,0891,6401,1431,055
Loss (Gain) From Sale of Assets
22.01-52.53-520.942.0831.530.62
Asset Writedown & Restructuring Costs
32.6732.6712,215438.73-509.63
Loss (Gain) From Sale of Investments
-266.23-267.01-15,885-120.89-164.96137.71
Loss (Gain) on Equity Investments
763.68-2,3241,121---
Stock-Based Compensation
-173.44288.54105.02431.59454.54
Provision & Write-off of Bad Debts
8.75-90.217.56124.0216.52-40.69
Other Operating Activities
-720.68-502.681,980943.52,2692,425
Change in Accounts Receivable
-1,873836.542,471-1,9901,2532,198
Change in Inventory
-3,635-3,891-1,370-266.03-397.13-2,194
Change in Accounts Payable
-453.79-2,4831,758-2,452946.47-253.52
Change in Other Net Operating Assets
-2,146453.15-2,3432,456-246.42370.51
Operating Cash Flow
-81.03568.986,8411,353-1,777-784.3
Operating Cash Flow Growth
--91.68%405.50%---

Investing Activities

Fiscal Year
TTMFY 2025FY 2024FY 2019FY 2018FY 2017
Period Ending
Sep '26 Dec '25 Dec '24 Dec '19 Dec '18 Dec '17
Capital Expenditures
-7,433-7,210-2,799-1,397-1,095-2,236
Sale of Property, Plant & Equipment
30103572.95424.013.4
Divestitures
----937.48-
Sale (Purchase) of Intangibles
-2.1--292.13-540.15-280.15-192.6
Investment in Securities
-39,1003,236-9,704-5,058617.853,559
Other Investing Activities
198.66-17,448-3443.2710537.98
Investing Cash Flow
-46,306-21,319-12,256-6,938309.091,172

Financing Activities

Fiscal Year
TTMFY 2025FY 2024FY 2019FY 2018FY 2017
Period Ending
Sep '26 Dec '25 Dec '24 Dec '19 Dec '18 Dec '17
Short-Term Debt Issued
--10,0001,892-1,725
Long-Term Debt Issued
--903.0910,914-1,400
Total Debt Issued
5,000-10,90312,806-3,125
Short-Term Debt Repaid
----5,546-371.25-1,400
Long-Term Debt Repaid
--1,168-1,045-1,961-480-580
Total Debt Repaid
-1,512-1,168-1,045-7,507-851.25-1,980
Net Debt Issued (Repaid)
3,488-1,1689,8595,299-851.251,145
Issuance of Common Stock
60,04919,0351,283---
Financing Cash Flow
63,53717,86711,1415,299-851.251,145

Net Cash Flow

Fiscal Year
TTMFY 2025FY 2024FY 2019FY 2018FY 2017
Period Ending
Sep '26 Dec '25 Dec '24 Dec '19 Dec '18 Dec '17
Foreign Exchange Rate Adjustments
-----0.353,833
Miscellaneous Cash Flow Adjustments
000---
Net Cash Flow
17,149-2,8835,726-286.08-2,3205,365

Free Cash Flow

Fiscal Year
TTMFY 2025FY 2024FY 2019FY 2018FY 2017
Period Ending
Sep '26 Dec '25 Dec '24 Dec '19 Dec '18 Dec '17
Free Cash Flow
-7,514-6,6424,042-43.8-2,872-3,020
Free Cash Flow Growth
------
Free Cash Flow Margin
-2.96%-3.23%2.95%-0.12%-13.98%-19.41%
Free Cash Flow Per Share
-223.16-203.19126.44-3.16-212.19-252.31
Levered Free Cash Flow
-11,549-15,677-1,808-540.14-
Unlevered Free Cash Flow
-11,090-15,216-2,554-2.9-

Additional Metrics

Fiscal Year
TTMFY 2025FY 2024FY 2019FY 2018FY 2017
Period Ending
Sep '26 Dec '25 Dec '24 Dec '19 Dec '18 Dec '17
Cash Interest Paid
732.74740.77698.18288.41207.01274.48
Cash Income Tax Paid
-55.79-18.3558.8217.44.95
Change in Working Capital
-8,108-5,084516.46-2,2521,556120.3